Aldosterone dysregulation, often driven by obesity and primary aldosteronism, affects up to 30% of patients with hypertension, many of whom are undiagnosed or untreated ... "Aldosterone pathway plays ...
The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period ...Primary Aldosteronism Diagnosis Hypertension Management Research Applications.